InsiderTrades

Form 4 for IRON Disc Medicine, Inc.

Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-28 · accession 0000950170-23-031149 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2023-06-30 2023-06-28 IRON Bryce Joanne CFO M - OptEx $1.01 +7,880 11.3K +228% +$7,959
DMT 2023-06-30 2023-06-28 IRON Bryce Joanne CFO S - Sale+OE $49.95 -10.1K 1,619 -86% -$503.1K
DT 2023-06-30 2023-06-28 IRON Bryce Joanne CFO M - OptEx $0.00 -7,880 526 -94% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-28 M A 7,880 $1.01 11,332 D — —
2 Common Common Stock 2023-06-28 S D 4,808 $49.30 6,524 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.80 to $49.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
3 Common Common Stock 2023-06-28 S D 359 $51.23 1,260 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.28, inclusive.
4 Common Common Stock 2023-06-28 S D 4,905 $50.50 1,619 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.87 to $50.76, inclusive.
5 Derivative Stock Option (Right to Buy) 2023-06-28 M D 7,880 $0.00 526 D $1.01 · — to 2029-11-05 7,880 Common Stock (F5) The shares underlying this option vest in 16 equal quarterly installments following September 13, 2019, subject to the Reporting Person's continued service on each such vesting date.